Clinical Trials

|

7

Chinese Regulatory Authority Approves IND Application of Oramed’s Oral Insulin Capsules

Oramed Pharmaceuticals Inc., a company developing of oral drug delivery systems, announced today that its Chinese partner, Hefei Tianhui Incubator …

|

Aerpio Pharmaceuticals Study for Diabetic Retinopathy Does Not Meet Endpoints

Aerpio Pharmaceuticals, a company focused on developing drugs to treat ocular diseases and diabetic complications, today announced top-line results …

|

First Patient Dosed in Trial for Ready-to-Use Glucagon for Exercise-Induced Hypoglycemia

Xeris Pharmaceuticals, Inc. announced it has begun dosing patients in a Phase 2 trial with its ready-to-use, room-temperature stable liquid glucagon …

| |

AstraZeneca’s Drug Successful in Patients with Coronary Artery Disease and Type 2 Diabetes

AstraZeneca’s drug Brilinta® met primary endpoints in Phase 3 trials, the company reported on Monday. The trials showed that Brilinta …

| |

StimLabs Enrolls First Patient in Trial Investigating New Treatment for Diabetic Foot Ulcers

StimLabs, a regenerative technology company announced that the first patient has been enrolled in the company’s clinical trial assessing the …

|

NeuroBo Pharma to Initiate Phase 3 Trials in Adult’s with Diabetic Neuropathic Pain

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on novel, disease-modifying therapies for neurodegenerative diseases …

|

Clinical Trials: Should I Be in One?

What you need to know about being part of a diabetes research study.

|